Biolase Revenue 2010-2024 | BIOL
Biolase revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Biolase Annual Revenue
(Millions of US $) |
| 2023 |
$49 |
| 2022 |
$48 |
| 2021 |
$39 |
| 2020 |
$23 |
| 2019 |
$38 |
| 2018 |
$46 |
| 2017 |
$47 |
| 2016 |
$52 |
| 2015 |
$48 |
| 2014 |
$48 |
| 2013 |
$56 |
| 2012 |
$57 |
| 2011 |
$49 |
| 2010 |
$26 |
| 2009 |
$43 |
Biolase Quarterly Revenue
(Millions of US $) |
| 2024-03-31 |
$10 |
| 2023-12-31 |
$13 |
| 2023-09-30 |
$11 |
| 2023-06-30 |
$14 |
| 2023-03-31 |
$10 |
| 2022-12-31 |
$14 |
| 2022-09-30 |
$12 |
| 2022-06-30 |
$12 |
| 2022-03-31 |
$10 |
| 2021-12-31 |
$12 |
| 2021-09-30 |
$10 |
| 2021-06-30 |
$9 |
| 2021-03-31 |
$8 |
| 2020-12-31 |
$9 |
| 2020-09-30 |
$7 |
| 2020-06-30 |
$3 |
| 2020-03-31 |
$5 |
| 2019-12-31 |
$10 |
| 2019-09-30 |
$9 |
| 2019-06-30 |
$9 |
| 2019-03-31 |
$10 |
| 2018-12-31 |
$13 |
| 2018-09-30 |
$11 |
| 2018-06-30 |
$12 |
| 2018-03-31 |
$10 |
| 2017-12-31 |
$13 |
| 2017-09-30 |
$11 |
| 2017-06-30 |
$13 |
| 2017-03-31 |
$11 |
| 2016-12-31 |
$14 |
| 2016-09-30 |
$13 |
| 2016-06-30 |
$14 |
| 2016-03-31 |
$11 |
| 2015-12-31 |
$15 |
| 2015-09-30 |
$11 |
| 2015-06-30 |
$12 |
| 2015-03-31 |
$11 |
| 2014-12-31 |
$13 |
| 2014-09-30 |
$13 |
| 2014-06-30 |
$10 |
| 2014-03-31 |
$12 |
| 2013-12-31 |
$15 |
| 2013-09-30 |
$12 |
| 2013-06-30 |
$14 |
| 2013-03-31 |
$15 |
| 2012-12-31 |
$19 |
| 2012-09-30 |
$14 |
| 2012-06-30 |
$12 |
| 2012-03-31 |
$12 |
| 2011-12-31 |
$13 |
| 2011-09-30 |
$13 |
| 2011-06-30 |
$12 |
| 2011-03-31 |
$11 |
| 2010-12-31 |
$10 |
| 2010-09-30 |
$6 |
| 2010-06-30 |
$6 |
| 2010-03-31 |
$4 |
| 2009-12-31 |
$10 |
| 2009-09-30 |
$12 |
| 2009-06-30 |
$14 |
| 2009-03-31 |
$7 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.003B |
$0.049B |
|
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
|
